Cynosure Group LLC raised its stake in shares of Fabrinet (NYSE:FN – Free Report) by 3.4% during the 3rd quarter, HoldingsChannel.com reports. The firm owned 1,560 shares of the technology company’s stock after acquiring an additional 51 shares during the quarter. Cynosure Group LLC’s holdings in Fabrinet were worth $369,000 as of its most recent filing with the SEC.
Several other hedge funds have also made changes to their positions in the stock. Driehaus Capital Management LLC boosted its stake in Fabrinet by 183.5% during the second quarter. Driehaus Capital Management LLC now owns 277,978 shares of the technology company’s stock worth $68,046,000 after buying an additional 179,943 shares in the last quarter. Clearbridge Investments LLC acquired a new stake in shares of Fabrinet during the 2nd quarter valued at about $27,911,000. DekaBank Deutsche Girozentrale increased its stake in Fabrinet by 3,831.4% in the third quarter. DekaBank Deutsche Girozentrale now owns 82,088 shares of the technology company’s stock valued at $19,465,000 after acquiring an additional 80,000 shares during the period. Rice Hall James & Associates LLC raised its position in Fabrinet by 89.1% in the second quarter. Rice Hall James & Associates LLC now owns 134,519 shares of the technology company’s stock worth $32,929,000 after purchasing an additional 63,398 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. lifted its stake in Fabrinet by 14.7% during the third quarter. Charles Schwab Investment Management Inc. now owns 480,550 shares of the technology company’s stock worth $113,621,000 after purchasing an additional 61,491 shares during the period. Institutional investors own 97.38% of the company’s stock.
Fabrinet Stock Performance
Shares of FN stock opened at $225.85 on Friday. The stock’s fifty day moving average is $243.94 and its 200-day moving average is $237.91. Fabrinet has a 52 week low of $159.30 and a 52 week high of $278.38. The stock has a market capitalization of $8.19 billion, a PE ratio of 26.73 and a beta of 0.95.
Wall Street Analyst Weigh In
Several equities research analysts have recently weighed in on FN shares. JPMorgan Chase & Co. upped their price objective on Fabrinet from $240.00 to $285.00 and gave the company a “neutral” rating in a research note on Tuesday, August 20th. Needham & Company LLC began coverage on Fabrinet in a research note on Tuesday, November 5th. They set a “buy” rating and a $280.00 price objective for the company. Rosenblatt Securities lifted their price objective on Fabrinet from $260.00 to $280.00 and gave the company a “buy” rating in a report on Tuesday, August 20th. Barclays assumed coverage on shares of Fabrinet in a report on Thursday, November 14th. They issued an “equal weight” rating and a $292.00 target price on the stock. Finally, B. Riley downgraded shares of Fabrinet from a “neutral” rating to a “sell” rating and cut their price target for the company from $194.00 to $178.00 in a report on Wednesday, November 20th. One investment analyst has rated the stock with a sell rating, three have given a hold rating and three have issued a buy rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Hold” and an average target price of $252.14.
Read Our Latest Analysis on FN
Insider Activity at Fabrinet
In other news, EVP Edward T. Archer sold 8,690 shares of the company’s stock in a transaction on Thursday, September 5th. The stock was sold at an average price of $220.26, for a total transaction of $1,914,059.40. Following the transaction, the executive vice president now owns 8,333 shares of the company’s stock, valued at $1,835,426.58. This represents a 51.05 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. 0.38% of the stock is currently owned by company insiders.
About Fabrinet
Fabrinet provides optical packaging and precision optical, electro-mechanical, and electronic manufacturing services in North America, the Asia-Pacific, and Europe. The company offers a range of advanced optical and electro-mechanical capabilities in the manufacturing process, including process design and engineering, supply chain management, manufacturing, printed circuit board assembly, advanced packaging, integration, final assembly, and testing.
Featured Articles
- Five stocks we like better than Fabrinet
- Stock Sentiment Analysis: How it Works
- Eli Lilly, Pfizer, and AstraZeneca: 2025 Vaccine Makers to Watch
- With Risk Tolerance, One Size Does Not Fit All
- DICK’S Sporting Goods: The Under-the-Radar Buy-and-Hold Winner
- Canada Bond Market Holiday: How to Invest and Trade
- 2 Cheap Quantum Computing Stocks to Buy Instead of Chasing IonQ
Want to see what other hedge funds are holding FN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Fabrinet (NYSE:FN – Free Report).
Receive News & Ratings for Fabrinet Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fabrinet and related companies with MarketBeat.com's FREE daily email newsletter.